Dupixent and Levaquin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dupixent (dupilumab) and Levaquin (levofloxacin). Common drug interactions include memory impairment among females and cellulitis among males.

The phase IV clinical study analyzes what interactions people have when they take Dupixent and Levaquin. It is created by eHealthMe based on reports of 93 people who take the same drugs from the FDA, and is updated regularly.

What is Dupixent?

Dupixent has active ingredients of dupilumab. eHealthMe is studying from 257,631 Dupixent users. Check the latest studies of Dupixent.

What is Levaquin?

Levaquin has active ingredients of levofloxacin. It is often used in sinusitis. eHealthMe is studying from 56,638 Levaquin users. Check the latest studies of Levaquin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

93 people who take Dupixent and Levaquin together, and have interactions are studied.

Dupixent and Levaquin drug interactions.

What are the common drug interactions of Dupixent and Levaquin, by gender? *:

female:

Memory impairment
Night sweats (sweating in night)
Osteoporosis (bones weak and more likely to break)
Palpitations (feelings or sensations that your heart is pounding or racing)
Peripheral swelling
Respiratory tract infection
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Spinal fracture (fracture in one of vertebrae)
Asthma
Arthralgia (joint pain)

male:

Cellulitis (infection under the skin)
Pruritus (severe itching of the skin)
Fatigue (feeling of tiredness)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Headache (pain in head)
Hyperhidrosis (abnormally increased sweating)
Injection site pain
Klebsiella infection
Limb injury
Micturition urgency (urgency to pass the urine)

What are the common drug interactions of Dupixent and Levaquin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Injection site pruritus (severe itching at injection site)

30-39:

Asthma
Headache (pain in head)
Oral herpes (viral infection of mouth)
Weight increased
Ear infection
Head injury
Influenza
Pharyngitis (inflammation of the pharynx, causing a sore throat)
Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)
Rash

40-49:

Dyspnoea (difficult or laboured respiration)
Injection site pain
Nausea (feeling of having an urge to vomit)
Neurological symptom (symptoms of nervous system disease)
Paranasal sinus discomfort
Surgery
Vomiting
Cough
Influenza
Asthma

50-59:

Arthralgia (joint pain)
Asthma
Retinal detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue)
Pain in extremity
Back disorder
Eye disorder
Eye haemorrhage (bleeding in the eye)
Injection site pain
Vision blurred
Visual impairment

60+:

Rash
Cellulitis (infection under the skin)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cough
Dehydration (dryness resulting from the removal of water)
Discomfort
Dry skin
Fatigue (feeling of tiredness)
Herpes zoster
Infusion site extravasation (flow of (blood or lymph) from infusion site)

What are the existing conditions these people have? *

Asthma: 44 people, 47.31%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 16 people, 17.20%
Immunodeficiency Common Variable: 7 people, 7.53%

* Approximation only. Some reports may have incomplete information.

Do you take Dupixent and Levaquin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously